期刊文献+
共找到154篇文章
< 1 2 8 >
每页显示 20 50 100
Association of TCF7L2 and GCG Gene Variants with Insulin Secretion,Insulin Resistance,and Obesity in New-onset Diabetes 被引量:1
1
作者 ZHANG Lu ZHANG Ming +13 位作者 WANG Jin Jin WANG Chong Jian REN Yong Cheng WANG Bing Yuan ZHANG Hong Yan YANG Xiang Yu ZHAO Yang HAN Cheng Yi ZHOU Jun Mei PANG Chao YIN Lei ZHAO Jing Zhi LUO Xin Ping HU Dong Sheng 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2016年第11期814-817,共4页
This cohort study was designed to evaluate the association of transcription factor 7-like 2 (TCF7L2) and proglucagon gene (GCG) variants with disordered glucose metabolism and the incidence of type 2 diabetes mell... This cohort study was designed to evaluate the association of transcription factor 7-like 2 (TCF7L2) and proglucagon gene (GCG) variants with disordered glucose metabolism and the incidence of type 2 diabetes mellitus (T2DM) in a rural adult Chinese population. A total of 7,751 non-T2DM participants 〉18 years old genotyped at baseline were recruited. The same questionnaire interview and physical and blood biochemical examinations were performed at both baseline and follow-up. During a median 6 years of follow-up, T2DM developed in 227 participants. After adjustment for potential contributory factors, nominally significant associations were seen between 3T genotype and the recessive model of TCFTI.2 rs7903146 and increased risk of T2DM [hazard ratio (HR)=4.068, 95% confidence interval (CI): 1.270-13.026; HR=4.051, 95% CI: 1.268-12.946, respectively]. The TT genotype of rs7903146 was also significantly associated with higher fasting plasma insulin level and the homeostasis model assessment of insulin resistance in case of new-onset diabetes. In addition, the TCF7L2 rs290487 TT genotype was associated with abdominal obesity and the GCG rs12104705 CC genotype was associated with both general obesity and abdominal obesity in case of new-onset diabetes. 展开更多
关键词 TCF GCG Insulin Resistance and Obesity in new-onset diabetes
下载PDF
New-onset diabetes secondary to acute pancreatitis:An update
2
作者 Xian-Qiang Yu Qian Zhu 《World Journal of Clinical Cases》 SCIE 2022年第30期10862-10866,共5页
Diabetes is a condition of persistent hyperglycemia caused by the endocrine disorder of the pancreas.Therefore,all pancreatic diseases have the risk of diabetes.In particular,increasing attention has been paid recentl... Diabetes is a condition of persistent hyperglycemia caused by the endocrine disorder of the pancreas.Therefore,all pancreatic diseases have the risk of diabetes.In particular,increasing attention has been paid recently to new-onset diabetes secondary to acute pancreatitis(AP).The complications of secondary diabetes have caused a lot of trouble for patients and have garnered increasing attention.At present,the pathophysiological mechanism of new-onset diabetes caused by AP is not clear.This review summarizes the current understanding of new-onset diabetes secondary to AP. 展开更多
关键词 Acute pancreatitis new-onset diabetes β-cell HYPERGLYCEMIA
下载PDF
Organophosphate pesticides and new-onset diabetes mellitus:From molecular mechanisms to a possible therapeutic perspective
3
作者 Ya-Ling Chung Yi-Chou Hou +2 位作者 I-Kuan Wang Kuo-Cheng Lu Tzung-Hai Yen 《World Journal of Diabetes》 SCIE 2021年第11期1818-1831,共14页
Organophosphate is a commonly used pesticide in the agricultural sector.The main action of organophosphate focuses on acetylcholinesterase inhibition,and it therefore contributes to acute cholinergic crisis,intermedia... Organophosphate is a commonly used pesticide in the agricultural sector.The main action of organophosphate focuses on acetylcholinesterase inhibition,and it therefore contributes to acute cholinergic crisis,intermediate syndrome and delayed neurotoxicity.From sporadic case series to epidemiologic studies,organophosphate has been linked to hyperglycemia and the occurrence of newonset diabetes mellitus.Organophosphate-mediated direct damage to pancreatic beta cells,insulin resistance related to systemic inflammation and excessive hepatic gluconeogenesis and polymorphisms of the enzyme governing organophosphate elimination are all possible contributors to the development of newonset diabetes mellitus.To date,a preventive strategy for organophosphatemediated new-onset diabetes mellitus is still lacking.However,lowering reactive oxygen species levels may be a practical method to reduce the risk of developing hyperglycemia. 展开更多
关键词 ORGANOPHOSPHATE PESTICIDE new-onset diabetes mellitus Mechanism Reactive oxygen species
下载PDF
Autoantigen administration confers diabetes-preventive properties to NOD mice derived dendritic cells
4
作者 MING XIANG XIAO LEI ZOU JING XU YAO YAO JIN FANG ZHANG 《Journal of Microbiology and Immunology》 2007年第1期69-77,共9页
Administration of autoantigen can be of value for prevention of autoimmune diabetes and it has been speculated that the control point of dendritic cells(DC)for the induction of peripheral toler- ance may be highly rel... Administration of autoantigen can be of value for prevention of autoimmune diabetes and it has been speculated that the control point of dendritic cells(DC)for the induction of peripheral toler- ance may be highly relevant.We examined the properties of DC associated with immune suppression in NOD mice by insulin injection subcutaneously and their ability to suppress diabetes transfer by diabeto- genic effector cells in secondary NOD-SCID recipients.Our data showed that the surface expressions of MHCⅡand CD86 on NOD-derived DC were increased after insulin treatment compared with those on PBS controlled mice.The dendritic cells with a mature phenotype and increased MLR stimulation adop- tively transferred immune tolerogenic effects on secondary NOD-SCID mice,which were associated with significantly greater IL-10,TGF-beta production and CD4^+ CD25^+ T differentiation from splenocytes compared with NOD-SCID control recipients.Moreover,treatment with DC remarkably decreased the incidence of diabetes in secondary recipients.These results suggest that a subtype of DC generated by insulin subcutaneous treated NOD mice confers potential protection against diabetes through polarizing the immune response towards a Th2 regulatory pathway. 展开更多
关键词 diabetes Dendritic cells Immune tolerance nod mice
下载PDF
Minimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantation 被引量:12
5
作者 Jiu-Lin Song Wei Gao +11 位作者 Yan Zhong Lu-Nan Yan Jia-Yin Yang Tian-Fu Wen Bo Li Wen-Tao Wang Hong Wu Ming-Qing Xu Zhe-Yu Chen Yong-Gang Wei Li Jiang Jian Yang 《World Journal of Gastroenterology》 SCIE CAS 2016年第6期2133-2141,共9页
AbstractAIM: To investigate the impact of minimum tacrolimus(TAC) on new-onset diabetes mellitus (NODM) afterliver transplantation (LT).METHODS: We retrospectively analyzed the data of973 liver transplant reci... AbstractAIM: To investigate the impact of minimum tacrolimus(TAC) on new-onset diabetes mellitus (NODM) afterliver transplantation (LT).METHODS: We retrospectively analyzed the data of973 liver transplant recipients between March 1999and September 2014 in West China Hospital LiverTransplantation Center. Following the exclusion ofineligible recipients, 528 recipients with a TAC-dominantregimen were included in our study. We calculatedand determined the mean trough concentration ofTAC (cTAC) in the year of diabetes diagnosis in NODMrecipients or in the last year of the follow-up in non-NODM recipients. A cutoff of mean cTAC value forpredicting NODM 6 mo after LT was identified usinga receptor operating characteristic curve. TAC-relatedcomplications after LT was evaluated by χ^2 test, andthe overall and allograft survival was evaluated usingthe Kaplan-Meier method. Risk factors for NODM afterLT were examined by univariate and multivariate Cox regression.RESULTS: Of the 528 transplant recipients, 131(24.8%) developed NODM after 6 mo after LT, andthe cumulative incidence of NODM progressivelyincreased. The mean cTAC of NODM group recipientswas significantly higher than that of recipients in thenon-NODM group (7.66 ± 3.41 ng/mL vs 4.47 ± 2.22ng/mL, P 〈 0.05). Furthermore, NODM group recipientshad lower 1-, 5-, 10-year overall survival rates (86.7%,71.3%, and 61.1% vs 94.7%, 86.1%, and 83.7%, P 〈0.05) and allograft survival rates (92.8%, 84.6%, and75.7% vs 96.1%, 91%, and 86.1%, P 〈 0.05) thanthe others. The best cutoff of mean cTAC for predictingNODM was 5.89 ng/mL after 6 mo after LT. Multivariateanalysis showed that old age at the time of LT (〉 50years), hypertension pre-LT, and high mean cTAC (≥5.89 ng/mL) after 6 mo after LT were independent riskfactors for developing NODM. Concurrently, recipientswith a low cTAC (〈 5.89 ng/mL) were less likely tobecome obese (21.3% vs 30.2%, P 〈 0.05) or todevelop dyslipidemia (27.5% vs 44.8%, P 〈0.05),chronic kidney dysfunction (14.6% vs 22.7%, P 〈 0.05),and moderate to severe infection (24.7% vs 33.1%, P〈 0.05) after LT than recipients in the high mean cTACgroup. However, the two groups showed no significantdifference in the incidence of acute and chronicrejection, hypertension, cardiovascular events and newonsetmalignancy.CONCLUSION: A minimal TAC regimen can decreasethe risk of long-term NODM after LT. Maintaining a cTACvalue below 5.89 ng/mL after LT is safe and beneficial. 展开更多
关键词 Liver transplantation Minimum TACROLIMUS new-onset diabetes MELLITUS IMMUNOSUPPRESSANTS ALLOGRAFTS failure
下载PDF
New-onset diabetes after kidney transplantation:Incidence and associated factors 被引量:8
6
作者 Vania Gomes Florbela Ferreira +1 位作者 JoséGuerra Maria Joao Bugalho 《World Journal of Diabetes》 SCIE CAS 2018年第7期132-137,共6页
AIM To determine the incidence and associated factors of new-onset diabetes after transplantation(NODAT) in a Portuguese central hospital. METHODS This single-center retrospective study involved consecutive adult nond... AIM To determine the incidence and associated factors of new-onset diabetes after transplantation(NODAT) in a Portuguese central hospital. METHODS This single-center retrospective study involved consecutive adult nondiabetic transplant recipients, who had undergone kidney transplantation between January 2012 and March 2016. NODAT was diagnosed according to the criteria of the American Diabetes Association. Data were collected from an institutional database of the Nephrology and Kidney Transplantation Department(Santa Maria Hospital, Lisbon, Portugal) and augmented with data of laboratorial parameters collected from the corresponding patient electronic medical records. Exclusion criteria were preexisting diabetes mellitus, missing information and follow-up period of less than 12 mo. Data on demographic and clinical characteristics as well as anthropometric and laboratorial parameters were also collected. Patients were divided into two groups: With and without NODAT-for statistical comparison.RESULTS A total of 156 patients received kidney transplantduring the study period, 125 of who were included in our analysis. NODAT was identified in 27.2% of the patients(n = 34; 53% female; mean age: 49.5 ± 10.8 years; median follow-up: 36.4 ± 2.5 mo). The incidence in the first year was 24.8%. The median time to diagnosis was 3.68 ± 5.7 mo after transplantation, and 76.5% of the patients developed NODAT in the first 3 mo. In the group that did not develop NODAT(n = 91), 47% were female, with mean age of 46.4 ± 13.5 years and median follow-up of 35.5 ± 1.6 mo. In the NODAT group, the pretransplant fasting plasma glucose(FPG) levels were significantly higher [101(96.1-105.7) mg/d L vs 92(91.4-95.8) mg/d L, P = 0.007] and pretransplant impaired fasting glucose(IFG) was significantly more frequent(51.5% vs 27.7%, P = 0.01). Higher pretransplant FPG levels and pretransplant IFG were found to be predictive risk factors for NODAT development [odds ratio(OR): 1.059, P = 0.003; OR: 2.772, P = 0.017, respectively]. CONCLUSION NODAT incidence was high in our renal transplant recipients, particularly in the first 3 mo posttransplant, and higher pretransplant FPG level and IFG were risk factors. 展开更多
关键词 new-onset diabetes AFTER transplant INCIDENCE Kidney transplantation Impaired FASTING glucose IMMUNOSUPPRESSION
下载PDF
Maresin1通过抑制NOD样受体家族蛋白3炎症小体活化改善糖尿病大鼠视网膜炎症反应
7
作者 张博 李凤君 +1 位作者 刘学政 左中夫 《中国当代医药》 CAS 2023年第13期5-9,共5页
目的探讨Maresin1(MaR1)通过抑制NOD样受体家族蛋白3(NLRP3)炎症小体介导的炎症反应来保护大鼠糖尿病视网膜病变(DR)。方法SPF级SD大鼠,建立糖尿病模型。按照随机数字表法分为4组:正常(Con)组、糖尿病(DM)组、MaR1组、MaR1+NLRP3激活剂... 目的探讨Maresin1(MaR1)通过抑制NOD样受体家族蛋白3(NLRP3)炎症小体介导的炎症反应来保护大鼠糖尿病视网膜病变(DR)。方法SPF级SD大鼠,建立糖尿病模型。按照随机数字表法分为4组:正常(Con)组、糖尿病(DM)组、MaR1组、MaR1+NLRP3激活剂尼日利亚菌素组(Nigericin)组。成模后,MaR1组4 ng/g MaR1腹腔注射给药,每周2次,Con组和DM组给予等量PBS注射。Nigericin组1 mg/kg Nigericin每天1次腹腔注射和4 ng/g MaR1每周2次腹腔注射联合给药。HE染色观察组织病理改变。免疫组化检测神经胶质纤维酸性蛋白(GFAP)表达。ELISA测定视网膜白介素(IL)-18、IL-1β、IL-6水平。Western blot检测视网膜IL-18、IL-1β、IL-6、NLRP3、凋亡相关斑点样蛋白(ASC)、天冬酰胺特异酶半胱氨酸蛋白酶(Caspase-1)表达。结果DM组神经节细胞(RGC)数量明显少于Con组,GFAP表达高于Con组,IL-18、IL-1β、IL-6、NLRP3、ASC、Caspase-1表达水平高于Con组,差异有统计学意义(P<0.05)。MaR1组RGC数量多于DM组,GFAP表达低于DM组,IL-18、IL-1β、IL-6、NLRP3、ASC、Caspase-1表达水平低于DM组,差异有统计学意义(P<0.01)。然而在MaR1组基础上给予NLRP3激活剂Nigericin后,MaR1的保护作用被逆转。结论MaR1能够明显抑制DR炎症反应,这可能与抑制NLRP3炎症小体激活有关。 展开更多
关键词 Maresin1 糖尿病视网膜病变 nod样受体家族蛋白3 炎症
下载PDF
Heterogeneously elevated branched-chain/aromatic amino acids among new-onset type-2 diabetes mellitus patients are potentially skewed diabetes predictors
8
作者 Min Wang Yang Ou +7 位作者 Xiang-Lian Yuan Xiu-Fang Zhu Ben Niu Zhuang Kang Bing Zhang Anwar Ahmed Guo-Qiang Xing Heng Su 《World Journal of Diabetes》 SCIE 2024年第1期53-71,共19页
BACKGROUND The lack of specific predictors for type-2 diabetes mellitus(T2DM)severely impacts early intervention/prevention efforts.Elevated branched-chain amino acids(BCAAs:Isoleucine,leucine,valine)and aromatic amin... BACKGROUND The lack of specific predictors for type-2 diabetes mellitus(T2DM)severely impacts early intervention/prevention efforts.Elevated branched-chain amino acids(BCAAs:Isoleucine,leucine,valine)and aromatic amino acids(AAAs:Tyrosine,tryptophan,phenylalanine)show high sensitivity and specificity in predicting diabetes in animals and predict T2DM 10-19 years before T2DM onset in clinical studies.However,improvement is needed to support its clinical utility.AIM To evaluate the effects of body mass index(BMI)and sex on BCAAs/AAAs in new-onset T2DM individuals with varying body weight.METHODS Ninety-seven new-onset T2DM patients(<12 mo)differing in BMI[normal weight(NW),n=33,BMI=22.23±1.60;overweight,n=42,BMI=25.9±1.07;obesity(OB),n=22,BMI=31.23±2.31]from the First People’s Hospital of Yunnan Province,Kunming,China,were studied.One-way and 2-way ANOVAs were conducted to determine the effects of BMI and sex on BCAAs/AAAs.RESULTS Fasting serum AAAs,BCAAs,glutamate,and alanine were greater and high-density lipoprotein(HDL)was lower(P<0.05,each)in OB-T2DM patients than in NW-T2DM patients,especially in male OB-T2DM patients.Arginine,histidine,leucine,methionine,and lysine were greater in male patients than in female patients.Moreover,histidine,alanine,glutamate,lysine,valine,methionine,leucine,isoleucine,tyrosine,phenylalanine,and tryptophan were significantly correlated with abdominal adiposity,body weight and BMI,whereas isoleucine,leucine and phenylalanine were negatively correlated with HDL.CONCLUSION Heterogeneously elevated amino acids,especially BCAAs/AAAs,across new-onset T2DM patients in differing BMI categories revealed a potentially skewed prediction of T2DM development.The higher BCAA/AAA levels in obese T2DM patients would support T2DM prediction in obese individuals,whereas the lower levels of BCAAs/AAAs in NW-T2DM individuals may underestimate T2DM risk in NW individuals.This potentially skewed T2DM prediction should be considered when BCAAs/AAAs are to be used as the T2DM predictor. 展开更多
关键词 Hyperaminoacidemia Branched-chain/aromatic amino acids new-onset type-2 diabetes Predictor Obesity SEX
下载PDF
A novel clinical model for risk prediction and stratification of new-onset diabetes mellitus after distal pancreatectomy
9
作者 Zhihong Chen Ning Shi +7 位作者 Cheng Xing Yiping Zou Yuanpeng Zhang Zhenrong Chen Fan Wu Haosheng Jin Rufu Chen Menghua Dai 《Hepatobiliary Surgery and Nutrition》 SCIE 2023年第6期868-881,共14页
Background:The incidence of new-onset diabetes mellitus(NODM)after distal pancreatectomy(DP)remains high.Few studies have focused on NODM in patients with pancreatic benign or low-grade malignant lesions(PBLML).This s... Background:The incidence of new-onset diabetes mellitus(NODM)after distal pancreatectomy(DP)remains high.Few studies have focused on NODM in patients with pancreatic benign or low-grade malignant lesions(PBLML).This study aimed to develop and validate an effective clinical model for risk prediction and stratification of NODM after DP in patients with PBLML.Methods:A follow-up survey was conducted to investigate NODM in patients without preoperative DM who underwent DP.Four hundred and forty-eight patients from Peking Union Medical College Hospital(PUMCH)and 178 from Guangdong Provincial People’s Hospital(GDPH)met the inclusion criteria.They constituted the training cohort and the validation cohort,respectively.Univariate and multivariate Cox regression,as well as least absolute shrinkage and selection operator(LASSO)analyses,were used to identify the independent risk factors.The nomogram was constructed and verified.Concordance index(C-index),receiver operating characteristic(ROC)curve,calibration curves,and decision curve analysis(DCA)were applied to assess its predictive performance and clinical utility.Accordingly,the optimal cut-off point was determined by maximally selected rank statistics method,and the cumulative risk curves for the high-and low-risk populations were plotted to evaluate the discrimination ability of the nomogram.Results:The median follow-up duration was 42.8 months in the PUMCH cohort and 42.9 months in the GDPH cohort.The postoperative cumulative 5-year incidences of DM were 29.1%and 22.1%,respectively.Age,body mass index(BMI),length of pancreatic resection,intraoperative blood loss,and concomitant splenectomy were significant risk factors.The nomogram demonstrated significant predictive utility for post-pancreatectomy DM.The C-indexes of the nomogram were 0.739 and 0.719 in the training and validation cohorts,respectively.ROC curves demonstrated the predictive accuracy of the nomogram,and the calibration curves revealed that prediction results were in general agreement with the actual results.The considerable clinical applicability of the nomogram was certified by DCA.The optimal cut-off point for Background:The incidence of new-onset diabetes mellitus(NODM)after distal pancreatectomy(DP)remains high.Few studies have focused on NODM in patients with pancreatic benign or low-grade malignant lesions(PBLML).This study aimed to develop and validate an effective clinical model for risk prediction and stratification of NODM after DP in patients with PBLML.Methods:A follow-up survey was conducted to investigate NODM in patients without preoperative DM who underwent DP.Four hundred and forty-eight patients from Peking Union Medical College Hospital(PUMCH)and 178 from Guangdong Provincial People’s Hospital(GDPH)met the inclusion criteria.They constituted the training cohort and the validation cohort,respectively.Univariate and multivariate Cox regression,as well as least absolute shrinkage and selection operator(LASSO)analyses,were used to identify the independent risk factors.The nomogram was constructed and verified.Concordance index(C-index),receiver operating characteristic(ROC)curve,calibration curves,and decision curve analysis(DCA)were applied to assess its predictive performance and clinical utility.Accordingly,the optimal cut-off point was determined by maximally selected rank statistics method,and the cumulative risk curves for the high-and low-risk populations were plotted to evaluate the discrimination ability of the nomogram.Results:The median follow-up duration was 42.8 months in the PUMCH cohort and 42.9 months in the GDPH cohort.The postoperative cumulative 5-year incidences of DM were 29.1%and 22.1%,respectively.Age,body mass index(BMI),length of pancreatic resection,intraoperative blood loss,and concomitant splenectomy were significant risk factors.The nomogram demonstrated significant predictive utility for post-pancreatectomy DM.The C-indexes of the nomogram were 0.739 and 0.719 in the training and validation cohorts,respectively.ROC curves demonstrated the predictive accuracy of the nomogram,and the calibration curves revealed that prediction results were in general agreement with the actual results.The considerable clinical applicability of the nomogram was certified by DCA.The optimal cut-off point for risk prediction value was 2.88, and the cumulative risk curves of each cohort showed significant differences between the high- and low-risk groups. Conclusions: The nomogram could predict and identify the NODM risk population, and provide guidance to physicians in monitoring and controlling blood glucose levels in PBLML patients after DP. 展开更多
关键词 new-onset diabetes mellitus(nodM) pancreatic benign or low-grade malignant lesions(PBLML) distal pancreatectomy(DP) NOMOGRAM
原文传递
IL-4对NOD小鼠1型糖尿病免疫干预及其机制的探讨 被引量:11
10
作者 郭清华 张志利 +1 位作者 何国芬 闫彩风 《中国糖尿病杂志》 CAS CSCD 2001年第2期105-108,共4页
目的 探讨 IL - 4对 NOD鼠 1型糖尿病发病率、胰岛炎的影响及其机制。方法 采用人类 1型糖尿病动物模型 NOD(nonobese diabetic)鼠 ,IL - 4处理后检测血糖、尿糖及糖尿病发病率 ,HE染色观察胰岛炎程度 ,流式细胞仪测定周围及中枢淋巴... 目的 探讨 IL - 4对 NOD鼠 1型糖尿病发病率、胰岛炎的影响及其机制。方法 采用人类 1型糖尿病动物模型 NOD(nonobese diabetic)鼠 ,IL - 4处理后检测血糖、尿糖及糖尿病发病率 ,HE染色观察胰岛炎程度 ,流式细胞仪测定周围及中枢淋巴细胞亚群的变化。结果  IL - 4处理组糖尿病发病率为 12 .5 0 % ,明显低于对照组 (6 2 .5 0 % ) (P<0 .0 5 ) ,且胰岛炎的严重程度亦低于对照组 ;处理组周围单个核细胞 CD+ 4 / CD+ 8及 IL - 2 R+ 细胞百分比增高 ,胸腺 CD+ 4 CD+ 8细胞百分比增高而 CD+ 4 CD+ 8细胞百分比下降 (P<0 .0 1)。结论 IL- 4有降低 NOD鼠 1型糖尿病发病率及胰岛炎严重程度的作用 ;这种作用可能与 IL- 展开更多
关键词 1型糖尿病 nod小鼠 IL-4 免疫干预 免疫调节
下载PDF
人胰岛素基因在乳酸菌中的表达及其对非肥胖糖尿病(NOD)小鼠的作用 被引量:15
11
作者 陈思维 钟瑾 还连栋 《微生物学报》 CAS CSCD 北大核心 2007年第6期987-991,共5页
为实现人胰岛素基因在乳酸菌中的表达及探索其用作口服疫苗治疗Ⅰ型糖尿病(T1DM)的可行性,首先将人胰岛素基因密码子替换为乳酸菌偏爱密码子,同时在A,B链序列间加入连接短肽序列,经引物退火拼接合成人胰岛素基因。克隆至乳酸菌表达载体... 为实现人胰岛素基因在乳酸菌中的表达及探索其用作口服疫苗治疗Ⅰ型糖尿病(T1DM)的可行性,首先将人胰岛素基因密码子替换为乳酸菌偏爱密码子,同时在A,B链序列间加入连接短肽序列,经引物退火拼接合成人胰岛素基因。克隆至乳酸菌表达载体中后,利用电击转化法实现了带信号肽SPUsp45的人胰岛素基因在乳酸乳球菌(Lactococcus lactis)MG1363和干酪乳杆菌(Lactobacillus casei)ATCC27092中的表达。Western blot检测显示重组胰岛素位于细胞壁上,当菌体生长到OD600为0.4时达到最大表达量。用含有表达重组人胰岛素的Lactobacillus caseiATCC27092/pSW501菌体饲喂非肥胖糖尿病(NOD)小鼠,发现可刺激小鼠产生特异性抗体,同时使与免疫耐受相关的细胞因子IL-4水平明显升高(38.583±2.083pg/mL,P<0.05),提示其对NOD小鼠产生免疫耐受有一定的作用,为研制乳酸菌口服疫苗防治T1DM的可行性进行了有益的探索。 展开更多
关键词 胰岛素 干酪乳杆菌 乳酸乳球菌 表达 非肥胖糖尿病(nod)小鼠
下载PDF
吡格列酮对NOD鼠糖尿病的预防作用及其机制探讨 被引量:5
12
作者 孙曙光 周智广 +3 位作者 张松 罗建华 孙意 张翼 《中国糖尿病杂志》 CAS CSCD 北大核心 2007年第4期235-238,共4页
目的探讨吡格列酮(PIO)对NOD鼠糖尿病发病率和胰岛炎的影响及其作用机制。方法4周龄NOD雌鼠随机分为2组,分别摄食0.02%PIO混合饲料(PIO,n=26)和普通饲料(对照组,n=25),观察30周龄时的糖尿病累积发病率。各组另取12周龄未患病NOD鼠(n=15... 目的探讨吡格列酮(PIO)对NOD鼠糖尿病发病率和胰岛炎的影响及其作用机制。方法4周龄NOD雌鼠随机分为2组,分别摄食0.02%PIO混合饲料(PIO,n=26)和普通饲料(对照组,n=25),观察30周龄时的糖尿病累积发病率。各组另取12周龄未患病NOD鼠(n=15)胰腺H-E染色观察胰岛炎;ELISA法测血清、脾细胞培养上清干扰素γ(IFN-γ)和白细胞介素4(IL-4)水平;RT-PCR检测脾脏IL-4、IFN-γ mRNA的表达水平。结果30周龄时,PIO组发病率较对照组明显降低(P<0.05)。12周龄时,PIO组胰岛炎平均积分低于对照组(P<0.05);血清、脾上清IL-4水平,脾脏IL-4 mRNA表达水平显著性高于对照组(P<0.05);PIO血清、脾上清IL-4/IFN-γ比值水平高于对照组(P<0.05)。结论PIO通过上调IL-4水平,促使免疫平衡向Th2方向偏移,从而使NOD鼠胰岛炎减轻,而在一定程度上预防和延缓NOD鼠糖尿病的发生。 展开更多
关键词 nod 吡格列酮 糖尿病 1型 胰岛炎 辅助性T细胞
下载PDF
己酮可可碱对NOD小鼠1型糖尿病的免疫干预作用 被引量:4
13
作者 施念玮 吴艺捷 +1 位作者 王煜非 顾丽萍 《上海医学》 CAS CSCD 北大核心 2005年第10期877-880,F0003,共5页
目的观察己酮可可碱(PTX)对NOD小鼠1型糖尿病的免疫干预作用及其机制。方法采用NOD小鼠以环磷酰胺加速发病,给PTX后测血糖、糖尿病患病率,苏木精伊红染色及免疫组织化学法观察胰岛炎,采用半定量逆转录聚合酶链反应(RTPCR)分析胰腺组织... 目的观察己酮可可碱(PTX)对NOD小鼠1型糖尿病的免疫干预作用及其机制。方法采用NOD小鼠以环磷酰胺加速发病,给PTX后测血糖、糖尿病患病率,苏木精伊红染色及免疫组织化学法观察胰岛炎,采用半定量逆转录聚合酶链反应(RTPCR)分析胰腺组织γ干扰素(IFNγ)、肿瘤坏死因子α(TNFα)、白介素10(IL10)mRNA的表达。结果实验结束时,PTX组的血糖值为13.04mmol/L,明显低于对照组的20.53mmol/L(P<0.01);胰岛炎评分为1.02±0.98,明显低于对照组的2.27±1.22(P<0.05);糖尿病患病率为40.63%,明显低于对照组的71.43%(P<0.05);胰腺组织IFNγ、TNFαmRNA的表达降低(P<0.05),IL10mRNA的表达无明显改变。结论PTX可预防NOD小鼠糖尿病的发生,其机制可能与下调胰腺组织辅助性T细胞1型细胞因子有关。 展开更多
关键词 己酮可可碱 1型糖尿病 nod 细胞因子 预防
下载PDF
苏木提取物对NOD小鼠1型糖尿病的免疫干预作用研究 被引量:5
14
作者 刘雪芹 于湄 白凤楼 《医药导报》 CAS 2009年第4期433-436,共4页
目的研究苏木提取物对NOD小鼠1型糖尿病发病的免疫干预作用,并初步探讨其作用机制。方法采用4周龄NOD小鼠,不同剂量的苏木乙酸乙酯提取物和正丁醇提取物分别灌胃给药,连续观察对NOD小鼠糖尿病发病率的影响。28周龄时处死小鼠,取胰腺组... 目的研究苏木提取物对NOD小鼠1型糖尿病发病的免疫干预作用,并初步探讨其作用机制。方法采用4周龄NOD小鼠,不同剂量的苏木乙酸乙酯提取物和正丁醇提取物分别灌胃给药,连续观察对NOD小鼠糖尿病发病率的影响。28周龄时处死小鼠,取胰腺组织做苏木精-伊红(HE)染色,行胰岛炎评分。分离脾脏淋巴细胞,噻唑蓝(MTT)法测定小鼠脾淋巴细胞增殖反应,ELISA法测定脾淋巴细胞培养上清液中细胞因子干扰素(IFN)-γ和白细胞介素(IL)-10含量。结果不同剂量的两种苏木提取物均可剂量依赖性地降低NOD小鼠的发病率,并显著改善小鼠体内胰岛炎的严重程度。体外实验发现,与模型对照组相比,苏木提取物可显著抑制脾脏淋巴细胞增殖能力,并抑制Th1型细胞因子IFN-γ的产生,促进Th2型细胞因子IL-10的分泌。结论苏木提取物免疫干预后可显著降低NOD小鼠的糖尿病发病率,其机制与改善体内Th型细胞因子失衡状态并抑制淋巴细胞增殖有关。 展开更多
关键词 苏木 糖尿病 1型 nod 免疫干预
下载PDF
NOD小鼠糖尿病早期Th1细胞与CD4^+CD25^+Treg细胞的变化 被引量:3
15
作者 王弘珺 李质馨 +2 位作者 田洪艳 徐冶 刘忠平 《解放军医学杂志》 CAS CSCD 北大核心 2013年第11期888-891,共4页
目的研究Th1细胞和CD4+CD25+Treg细胞在NOD小鼠糖尿病早期的变化,并评价其作用。方法选择4周(A组)、8周(B组)和16周龄(C组)的雌性NOD小鼠,取脾、胸腺和胰腺组织,采用流式细胞术测定脾Th1和CD4+CD25+Treg细胞的比例,计算Th1/CD4+T、CD4+C... 目的研究Th1细胞和CD4+CD25+Treg细胞在NOD小鼠糖尿病早期的变化,并评价其作用。方法选择4周(A组)、8周(B组)和16周龄(C组)的雌性NOD小鼠,取脾、胸腺和胰腺组织,采用流式细胞术测定脾Th1和CD4+CD25+Treg细胞的比例,计算Th1/CD4+T、CD4+CD25+Treg/CD4+T和Th1/CD4+CD25+Treg的比值,再测定胸腺CD4–CD8–T、CD4+CD8+T、CD4–CD8+T和CD4+CD8–T细胞比例,计算CD25+Treg/CD4+CD8–T的比值。取胰腺组织,行HE染色和Foxp3免疫组化染色,观察胰腺病理学变化。结果 C组小鼠脾脏Th1细胞比例以及Th1/CD4+T和Th1/CD4+CD25+Treg比值明显高于A组和B组,但是A、B、C三组脾脏CD4+CD25+Treg细胞比例及CD4+CD25+Treg/CD4+T比值差异无统计学意义。三组间胸腺CD4–CD8–T、CD4+CD8+T、CD4–CD8+T和CD4+CD8–T细胞比例差异无统计学意义,但是B组和C组胸腺CD25+Treg/CD4+CD8–T比值明显高于A组。HE染色结果显示,B组和C组的胰岛周围可见淋巴细胞浸润,但胰岛周围淋巴细胞浸润部位免疫组化染色未见Foxp3阳性细胞。结论 NOD小鼠糖尿病早期外周Th1细胞呈进行性增加,但CD4+CD25+Treg细胞相对缺乏,考虑与NOD小鼠糖尿病进展有关。 展开更多
关键词 小鼠 近交nod TH1细胞 CD4+CD25+调节性T细胞 糖尿病 1型
下载PDF
NOD小鼠人源化后CD4~+ Tregs和CD8~+ Tregs频率和功能变化及意义 被引量:5
16
作者 张梦军 韩清娟 +2 位作者 陈晓玲 陈禹彤 王莉 《免疫学杂志》 CAS CSCD 北大核心 2018年第1期19-26,共8页
目的观察NOD小鼠人源化后,CD4^+和CD8^+调节性T细胞(regulatory T cells,Tregs)频率和功能的变化,揭示Tregs在人源化NOD小鼠1型糖尿病中的作用及免疫学机制可能的变化。方法流式细胞术分别分析12周龄未发病的人源化NOD小鼠和NOD小鼠脾... 目的观察NOD小鼠人源化后,CD4^+和CD8^+调节性T细胞(regulatory T cells,Tregs)频率和功能的变化,揭示Tregs在人源化NOD小鼠1型糖尿病中的作用及免疫学机制可能的变化。方法流式细胞术分别分析12周龄未发病的人源化NOD小鼠和NOD小鼠脾淋巴细胞和胰腺淋巴结细胞中CD8^+CD122^+T、CD8^+CD28-T、CD8^+CD25^+Foxp3^+T和CD4^+CD25^+Foxp3^+T细胞的频率,并采用3H-Td R掺入法检测脾CD4^+CD25^+T和CD8^+CD25^+T细胞的免疫抑制功能。结果人源化NOD小鼠和NOD小鼠的脾淋巴细胞和胰腺淋巴结细胞中CD4^+CD25^+Foxp3^+T细胞频率无显著性差异(P>0.05),而人源化NOD小鼠脾淋巴细胞和胰腺淋巴结细胞中CD8^+CD122^+T、CD8^+CD28-T、CD8^+CD25^+Foxp3^+T细胞等CD8^+Tregs亚群的频率较NOD小鼠都显著降低,但NOD小鼠人源化后,CD4^+CD25^+T和CD8^+CD25^+T细胞的免疫抑制功能并没有显著性差异;同时与人源化NOD小鼠相比,NOD小鼠的胰腺淋巴结细胞中CD8^+T细胞频率更低。结论人源化NOD小鼠脾脏和胰腺淋巴结中CD8^+Tregs亚群频率的降低,引起其胰腺淋巴结中CD8^+T细胞频率的升高,导致胰岛β细胞破坏更严重,可能是引起人源化NOD小鼠自发1型糖尿病较NOD小鼠明显提前且加重的因素之一。 展开更多
关键词 1型糖尿病 人源化nod小鼠 CD4^+ TREGS CD8^+ TREGS
下载PDF
雷公藤多甙对NOD小鼠1型糖尿病免疫治疗的机理 被引量:2
17
作者 施念玮 吴艺捷 +2 位作者 王煜非 顾丽萍 林健 《老年医学与保健》 CAS 2005年第3期153-155,共3页
目的观察雷公藤多甙(TWP)对雌性非肥胖型糖尿病小鼠(NOD小鼠)1型糖尿病免疫预防作用并初步讨论其机理。方法采用NOD小鼠环磷酰胺加速发病,给TWP后观察糖尿病发病率、半定量RT-PCR分析胰腺组织干扰素γ(IFN-γ)、肿瘤坏死因子α(TNF-α)... 目的观察雷公藤多甙(TWP)对雌性非肥胖型糖尿病小鼠(NOD小鼠)1型糖尿病免疫预防作用并初步讨论其机理。方法采用NOD小鼠环磷酰胺加速发病,给TWP后观察糖尿病发病率、半定量RT-PCR分析胰腺组织干扰素γ(IFN-γ)、肿瘤坏死因子α(TNF-α)、白介素-10(IL-10)mRNA的表达。结果TWP组实验结束时糖尿病发病率(43.33%)低于对照组(71.43%)(P<0.05);胰腺组织IFN-γ、TNF-αmRNA的表达降低(P<0.01),IL-10mRNA的表达无明显改变。结论 TWP可预防NOD鼠糖尿病的发生,其机制可能与下调胰腺组织Th1细胞因子表达有关。 展开更多
关键词 雷公藤 小鼠 近交nod 糖尿病 1型 细胞因子类 皂苷类
下载PDF
Th1细胞在NOD小鼠糖尿病早期的应用 被引量:1
18
作者 王弘珺 李质馨 +4 位作者 杨柳 田洪艳 徐冶 朱辛为 刘忠平 《中国老年学杂志》 CAS CSCD 北大核心 2012年第7期1411-1412,共2页
目的评价Th1细胞对NOD小鼠糖尿病早期变化的作用。方法选择4 w、8 w和16 w的雌性NOD小鼠,采用流式细胞术测定脾Th1细胞,采用免疫组化法检测胰腺内Th1细胞。结果随年龄增加,雌性NOD小鼠脾和胰腺内Th1细胞逐渐增加。结论 Th1细胞参与NOD... 目的评价Th1细胞对NOD小鼠糖尿病早期变化的作用。方法选择4 w、8 w和16 w的雌性NOD小鼠,采用流式细胞术测定脾Th1细胞,采用免疫组化法检测胰腺内Th1细胞。结果随年龄增加,雌性NOD小鼠脾和胰腺内Th1细胞逐渐增加。结论 Th1细胞参与NOD小鼠糖尿病早期的病理过程。 展开更多
关键词 nod小鼠 1型糖尿病 TH1细胞
下载PDF
甲壳低聚糖对NOD鼠糖尿病的预防作用 被引量:3
19
作者 曹朝晖 李邦良 +2 位作者 乔新惠 周娣先 谭洁琼 《医学理论与实践》 2004年第1期1-3,共3页
目的 :探讨甲壳低聚糖对NOD鼠糖尿病的预防作用机制。方法 :将 5周龄未发病的NOD小鼠分为糖尿病预防组和对照组。预防组用 3 %甲壳低聚糖溶液作饮用水 ,对照组用冷开水作饮用水 ,连续 15周 ,定期测血糖 ,称体重 ,实验末计算糖尿病的发病... 目的 :探讨甲壳低聚糖对NOD鼠糖尿病的预防作用机制。方法 :将 5周龄未发病的NOD小鼠分为糖尿病预防组和对照组。预防组用 3 %甲壳低聚糖溶液作饮用水 ,对照组用冷开水作饮用水 ,连续 15周 ,定期测血糖 ,称体重 ,实验末计算糖尿病的发病率 ,HE染色观察胰岛炎。结果 :对照组 12周龄即出现高血糖 ,而预防组至实验结束仅有少数出现高血糖 ,两组相比具有显著差异性 (P <0 0 1)。NOD鼠预防组糖尿病发病率 (2 5% )低于对照组 (79% ) (P <0 0 5) ,同时减轻胰岛炎的严重程度 (P <0 0 5)。结论 :甲壳低聚糖对NOD鼠糖尿病的确有预防作用 ,其机制可能与甲壳低聚糖的非特异性免疫调节作用 ,及抗氧化等有关。 展开更多
关键词 甲壳低聚糖 nod 糖尿病 预防作用
下载PDF
己酮可可碱预防NOD鼠1型糖尿病的机理研究 被引量:1
20
作者 何军华 兰丽珍 +1 位作者 张志利 李昭瑛 《中国糖尿病杂志》 CAS CSCD 2002年第6期355-357,共3页
目的 探讨己酮可可碱 (Pentoxifylline,PTX)对非肥胖糖尿病 (NOD)小鼠 1型糖尿病发病率、胰岛炎的影响及其机制。 方法 采用动物模型 NOD鼠 ,注射环磷酰胺 (CP)加速其发病。给PTX药物后计算糖尿病发病率 ,HE染色观察胰岛炎 ,并用逆转... 目的 探讨己酮可可碱 (Pentoxifylline,PTX)对非肥胖糖尿病 (NOD)小鼠 1型糖尿病发病率、胰岛炎的影响及其机制。 方法 采用动物模型 NOD鼠 ,注射环磷酰胺 (CP)加速其发病。给PTX药物后计算糖尿病发病率 ,HE染色观察胰岛炎 ,并用逆转录 (RT) PCR法检测脾细胞干扰素 γ(IFN- γ)、肿瘤坏死因子 α(TNF- α)、白介素 10 (IL- 10 ) m RNA的表达。 结果  PTX组糖尿病发生率(30 .0 0 % )明显低于对照组 (6 7.86 % ) (P<0 .0 1) ;胰岛炎程度也明显减轻 (P<0 .0 0 1) ;脾细胞 IFN-γ、TNF- αm RNA的表达较对照组明显降低 (P<0 .0 5 ) ;IL- 10 m RNA的表达无明显改变。 结论 PTX可预防 NOD鼠发生糖尿病 ,其机制可能与纠正 Th1与 展开更多
关键词 己酮可可碱 nod 1型糖尿病 细胞因子
下载PDF
上一页 1 2 8 下一页 到第
使用帮助 返回顶部